Advertisement

Topics

Lava Therapeutics Company Profile

10:26 EDT 21st August 2018 | BioPortfolio

Lava Therapeutics’ proprietary platform is focused on developing next generation γδ T cell engaging bispecific antibodies to treat cancer. Our first-in-class immuno-oncology approach activates Vγ9Vδ2 T cells upon binding to membrane-expressed tumor targets. Lava’s vision is to develop therapeutics for the curative treatment of cancer. Founded in 2016, Lava Therapeutics is advancing cutting-edge research originating from the group of Dr. Hans van der Vliet at the VU University Medical Center and Cancer Center Amsterdam. www.lavatherapeutics.com


News Articles [712 Associated News Articles listed on BioPortfolio]

Series A round brings €16mm to Lava Therapeutics

Lava Therapeutics BV raised €16mm ($18.9mm) through its Series A round. Gilde Healthcare and Versant Ventures co-led, with additional participation from MRL Ventures Fund, Lupus Ventures, and Biox B...

Laze: The New Danger In Hawaii From Lava Reaching The Pacific

“Laze”, or lava morphing into a haze-is the result when hot lava mixes with the cool ocean, producing hydrochloric acid and steam, shooting particles of volcanic glass into the air. This new threa...

Funding round pulls in $18.7M for Lava

A round of Series B funding brought in approximately $18.7 million for Lava Therapeutics, which is developing bispecific gamm -More- 

First Injury Reported From Kilauea Lava Spatter

A man on a balcony in his home in Pahoa, Hawaii was injured by a lava spatter that resulted in a devastating injury to his leg from his “shin to his foot”.

Lava Claims ‘Hundreds’ More Homes on Hawaii’s Big Island, Officials Say

(NPR) – A wide, slow-moving river of lava from Kilauea volcano has claimed hundreds of additional homes in the southeastern corner of Hawaii’s Big Island, officials say, marking what could...

Dutch bispecific antibody developer nets $18.7 million from US, European VCs

Lava Therapeutics nets 16 million euros in Series B round and plans to decide on clinical drug candidate in oncology this year.

Lava raises €16M for gamma delta T cell platform

Lava raises €16M for gamma-delta T cell platform

PubMed Articles [457 Associated PubMed Articles listed on BioPortfolio]

Arnica compositum, Hekla lava and Acidum Nitricum Together are Superior to Arnica compositum Alone in the Local Treatment of Symptomatic Calcific Periarthritis of the Shoulder: A Pilot Study.

To evaluate the usefulness of Arnica compositum (AC) + Acidum nitricum (AN) + Hekla lava (HL) ointment in Emergency Medicine Department (EMD) as alternative non-pharmacological local treatment of pati...

Biofiltration of methane using hybrid mixtures of biochar, lava rock and compost.

Using hybrid packing materials in biofiltration systems takes advantage of both the inorganic and organic properties offered by the medium including structural stability and a source of available nutr...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Adhesive Failure of Lava Ultimate and Lithium Disilicate Crowns Bonded to Zirconia Abutments: A Prospective Within-Patient Comparison.

To demonstrate the influence of restorative material on the success of clinical bonding to zirconia.

Clinical Trials [151 Associated Clinical Trials listed on BioPortfolio]

One Year Clinical Evaluation of E-max CAD and Lava Ultimate Laminate Veneers

Restoration of anterior teeth using conservative approach allows clinicians to provide porcelain laminate veneers with excellent esthetics without extensive tooth structure removal. lamina...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1252 Associated Companies listed on BioPortfolio]

Lava Therapeutics

Lava Therapeutics’ proprietary platform is focused on developing next generation γδ T cell engaging bispecific antibodies to treat cancer. Our first-in-class immuno-onc...

CMEA Ventures

CMEA Ventures is a San Francisco based venture capital firm that was established in 1989 and specializes in high technology, life sciences, and alternative energy investments. We invest in both early ...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Sciessent

Sciessent, located in Wakefield, Mass., is a leader in providing customized solutions that enhance the value of partners’ products. Sciessent’s Agion, Agion Active and A...

More Information about "Lava Therapeutics" on BioPortfolio

We have published hundreds of Lava Therapeutics news stories on BioPortfolio along with dozens of Lava Therapeutics Clinical Trials and PubMed Articles about Lava Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lava Therapeutics Companies in our database. You can also find out about relevant Lava Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record